A study to assess the effect of ticagrelor in reducing the number of days with pain in patients with sickle cell disease

Trial Identifier: D5136C00008
Sponsor: AstraZeneca
NCTID:: NCT02482298
Start Date: July 2015
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English translation
Arabic translation
Dholou translation
French translation
Italian translation
Turkish translation
Swahili translation
English translation

Trial Locations

Country Location
Egypt Alexandria, Egypt, 21131
Egypt Cairo, Egypt, 11562
Egypt Cairo, Egypt, 11566
France Bordeaux Cedex, France, 33076
France PARIS Cedex 15, France, 75908
France Strasbourg, France, 67091
Italy Genova, Italy, 16128
Italy Palermo, Italy, 90127
Italy Verona, Italy, 37134
Kenya Kikuyu, Kenya, 00100
Kenya Kisian, Kenya, 40100
Kenya Nairobi, Kenya, 40100
Lebanon Beirut, Lebanon, 113-6044
Lebanon Beirut, Lebanon, 1107 2020
Turkey Adana, Turkey, 01130
Turkey Mersin, Turkey, 33079
Turkey Van, Turkey, 65080
United Kingdom Harrow, United Kingdom, HA1 3UJ
United Kingdom London, United Kingdom, E9 6SR
United Kingdom London, United Kingdom, N19 5NF
United Kingdom LONDON, United Kingdom, E1 1BB
United States of America, FL Miami, FL, United States of America, 33136
United States of America, MD Baltimore, MD, United States of America, 21287
United States of America, MD Bethesda, MD, United States of America, 20817
United States of America, SC Charleston, SC, United States of America, 29425
United States of America, VA Norfolk, VA, United States of America, 23507